Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tianjin Pharmaceutical Da Ren Tang Group Corp. has approved the appointment of Ms. Xie Xi as a new member of the Supervisory Committee, succeeding Mr. Xing Jianhua, whose term is ending. Ms. Xie Xi brings extensive experience in finance and management, having served various roles within the company since 2008. Her appointment will be finalized pending shareholder approval at a forthcoming general meeting.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Netflix Wins Shareholder Lawsuit Alleging Misleading Growth Forecasts
- OpenAI’s Text-Video Generator Sora Leaked by Artists in Protest
- Palantir Gets New Street-High Price Target from Analysts on Nasdaq Shift
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
